Converting enzyme inhibitor or AT1-receptor blocker for decreasing long-term mortality in patients with stroke history and renal dysfunction?
Fournier
A
A
Godefroy
O
O
Oprisiu
R
R
Slama
M
M
Andrejak
M
M
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D007190:Indapamide / Q000627:therapeutic use; D007674:Kidney Diseases / Q000150:complications*; D020913:Perindopril / Q000627:therapeutic use; D017257:Ramipril / Q000627:therapeutic use; D044140:Receptor, Angiotensin, Type 1; D020521:Stroke / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality*
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D044140:Receptor, Angiotensin, Type 1; D007190:Indapamide; D017257:Ramipril; D020913:Perindopril